CME Group – CME

CME Group Inc , together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide.

infoCME Group is a large cap stock with a total market cap of 72.22B.

infoThey trade on the NASDAQ and had their IPO 20 years and 8 months ago.

infoCME Group currently employs 3460 people.

infoAs of Wednesday, Aug 23 2023, CME Group’s share price is $200.75.

News Relating to CME Group
Zacks Investment Research
Garden Variety Pullback or Bear Market Beginning? (3 Clues)

Thursday Aug 17 2023 at 17:02

Corrections are a necessary evil for those who want a sustained bull market. Stock Strategist Andrew Rocco provides evidence as to why the current pullback is “garden variety” and not the start of a new bear market.

Zacks Investment Research
Are Finance Stocks Lagging CME Group (CME) This Year?

Tuesday Aug 15 2023 at 16:11

Here is how CME Group (CME) and Robinhood Markets, Inc. (HOOD) have performed compared to their sector so far this year.

3 Dividend Stocks for August 2023

Sunday Aug 13 2023 at 07:00

A look at dividend prospects of three firms with wide or narrow Morningstar Economic Moat Ratings.

Market Watch
If America debt spiral gets worse, here’s the stock that may benefit, says fund manager

Friday Aug 11 2023 at 06:33

Wall Street is undecided about trying for another rally on Friday, according to early trading in futures. That’s in keeping with the struggle it has been of late, with the S&P 500 SPX down six of the last eight sessions amid August’s bearish tendencies.

Zacks Investment Research
3 Crypto Stocks to Keep a Tab on in August

Friday Aug 04 2023 at 09:47

As the cryptocurrency market is poised to pull out of its doldrums, it’s judicious for risk-tolerant investors to closely watch HIVE Blockchain (HIVE), Block (SQ) and CME Group (CME).

Zacks Investment Research
5 Stocks to Watch From the Prospering Securities and Exchanges Industry

Friday Jul 28 2023 at 14:45

Product innovation, increased market volatility and a strategic economic market model are expected to aid Securities and Exchanges stocks like CME, ICE, CBOE, NDAQ, and COIN. However, compliance with regulations remains a challenge.

Seeking Alpha
Dividend Investors Take Note – CME Group Is Back

Thursday Jul 27 2023 at 12:20

CME Group’s stock is up 18% year-to-date after strong earnings, validating the long-term bull case. The company saw growth in key segments like interest rates and commodities, demonstrating the scalability of its business model. CME’s higher rate per contract indicates increased profitability, and its commitment to steady dividend distributions makes it an attractive investment opportunity.

CME Group CEO Terry Duffy: Manage your risk because everyone I’ve talked to got Fed ‘dead wrong’

Wednesday Jul 26 2023 at 20:23

“It’s really hard to predict what the Fed is ultimately going to do,” CME Group Chairman and CEO Terry Duffy says.

Is CME Group Inc (CME) Fairly Valued? An In-Depth Analysis

Wednesday Jul 26 2023 at 18:32

With a daily gain of 3.94% and an Earnings Per Share (EPS) (EPS) of $7.87, CME Group Inc ( CME , Financial) has caught the attention of many investors. But is the stock fairly valued?

CNBC Television
CME Group CEO Terry Duffy reacts to Fed decision, A.I. and more

Wednesday Jul 26 2023 at 17:50

CME Group CEO Terry Duffy joins ‘Fast Money’ to talk the Fed’s decision to raise interest rates another 25 basis points, growth in A.I. and more.

Zacks Investment Research
CME Group (CME) Q2 Earnings Top on Higher Trading Volume

Wednesday Jul 26 2023 at 13:55

CME Group (CME) Q2 results reflect higher revenues on increased trading volume.

Zacks Investment Research
CME (CME) Reports Q2 Earnings: What Key Metrics Have to Say

Wednesday Jul 26 2023 at 10:56

The headline numbers for CME (CME) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks Investment Research
3 Crypto Stocks to Watch in the 2023 Ethereum Rally

Wednesday Jul 26 2023 at 09:25

Accenture (ACN), CME Group (CME) and HIVE Digital (HIVE) are three Ethereum-exposed stocks that should be tracked as the Bitcoin rival continues to rise in 2023.

Zacks Investment Research
CME Group (CME) Q2 Earnings and Revenues Top Estimates

Wednesday Jul 26 2023 at 09:25

CME Group (CME) came out with quarterly earnings of $2.30 per share, beating the Zacks Consensus Estimate of $2.18 per share. This compares to earnings of $1.97 per share a year ago.

Zacks Investment Research
CME Group (CME) Set to Report Q2 Earnings: What to Expect

Monday Jul 24 2023 at 13:05

CME Group’s (CME) Q2 earnings are likely to have been aided by improved clearing, transaction fees and other revenues, and market data and information services. However, higher expenses might have been an offset.

Seeking Alpha
4 Ideal Barron’s Mid-Year 2023 Dividend Dog Buys

Sunday Jul 23 2023 at 07:54

Barron’s Mid-Year Roundtable, Published July 17, listed 40 stocks of note for 2023; 38 of those were unduplicated US publicly-listed companies, of-which YCharts reported 25 as paying dividends. Barron’s interviews with their ten financial-industry Roundtable pros tapped human intelligence (HI) to make predictions. Unfortunately, the YCharts screener employed to report current data, dropped seven funds off the list. Nevertheless, the Watchlist tracked by YCharts as of 7/19/23 projected ten top analyst-estimated net gains from ICE, PARA, TXT, AZN, MLI, BIIB, SIEGY, CHNI, TGNA, & topped by SLVM, ranging from 15.53%-31.31%.

Zacks Investment Research
Will CME (CME) Beat Estimates Again in Its Next Earnings Report?

Monday Jul 17 2023 at 13:32

CME (CME) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Investment Research
Why Investors Need to Take Advantage of These 2 Finance Stocks Now

Monday Jul 17 2023 at 10:33

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

Zacks Investment Research
3 Incredible Stocks Trading at Historical Discounts

Thursday Jul 13 2023 at 15:37

When great stocks go on sale investors must act decisively.

Zacks Investment Research
Is CME Group (CME) Stock Outpacing Its Finance Peers This Year?

Thursday Jul 13 2023 at 11:07

Here is how CME Group (CME) and Capital Southwest (CSWC) have performed compared to their sector so far this year.

Zacks Investment Research
Why Investors Need to Take Advantage of These 2 Finance Stocks Now

Thursday Jul 06 2023 at 10:05

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Seeking Alpha
U.S. Wide-Moat Stocks On Sale – The July 2023 Heat Map

Thursday Jul 06 2023 at 09:31

Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may be worth your time for further analysis.

Zacks Investment Research
3 Stocks to Watch as Crypto Promises a July Rally

Wednesday Jul 05 2023 at 09:17

CME, NVDA and SHOP are three stocks that should be tracked as cryptocurrency starts off July on a positive note.

Zacks Investment Research
Here’s Why You Should Consider Buying CME Group (CME) Stock

Thursday Jun 29 2023 at 13:39

CME Group’s (CME) global presence, compelling product portfolio and focus on over-the-counter clearing services and effective capital deployment poise it well for growth.

Zacks Investment Research
CME (CME) Upgraded to Buy: What Does It Mean for the Stock?

Tuesday Jun 27 2023 at 13:33

CME (CME) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Seeking Alpha
URA: The Bull Case For Uranium Glows Brighter

Monday Jun 26 2023 at 16:53

URA: The Bull Case For Uranium Glows Brighter

CNBC Television
CME Group CEO Terry Duffy says companies need to be vigilant in managing risk

Wednesday Jun 21 2023 at 17:31

Terry Duffy, CME Group CEO, joins ‘Closing Bell’ to discuss recent comments from Federal Reserve Chair Jerome Powell and navigating market uncertainty.

Seeking Alpha
CME Group: A Good Defensive Financial Pick

Sunday Jun 18 2023 at 05:44

CME Group is down over 25% from its all-time high last year. The leading financial exchange should demonstrate great resilience during an economic slowdown, as it benefits from volatility. The rising popularity of 0DTE options should continue to be a meaningful growth driver of the company’s trading volume.

Seeking Alpha
2 Buffett-Style Dividend Bargains I Am Buying

Friday Jun 16 2023 at 09:00

My investment strategy, inspired by Warren Buffett, focuses on beaten-down stocks with value and growth characteristics for long-term outperformance. In this article, I explain what Buffett is looking for in a high-quality company and how this can help us build long-term wealth. I also show you two investments of mine that I recently bought more stock of. Two Buffett-like investments with a bright future.

CME Group Inc. Announces Second-Quarter 2023 Earnings Release, Conference Call

Thursday Jun 15 2023 at 14:30

CHICAGO , June 15, 2023 /PRNewswire/ — CME Group Inc. will announce earnings for the second quarter of 2023 before the markets open on Wednesday, July 26, 2023. Written highlights for the quarter will be posted on the company’s website at 6:00 a.m.

CME Group Bankruptcy Risk

The Altman Z-score is a formula that measures a company’s financial health and bankruptcy risk. It assigns a numerical score based on various financial ratios. The Z-score is divided into different zones. If the Z-score is above 2.99, it indicates a lower bankruptcy risk, classifying the company as ‘safe’ or ‘non-distressed’. If the score falls below 1.81, it suggests a higher risk, indicating potential financial distress or bankruptcy. The range between 1.81 and 2.99 is called the ‘gray zone’ or zone of ambiguity.

Learn more at Investopediaopen_in_new


CME Group’s Altman Z-score is 0.53 which is in the distress zone. This indicates a higher risk of financial distress and potential bankruptcy for the company. It can serve as a warning sign of significant financial challenges, requiring careful consideration by potential investors.

Derived from SEC.GOV filing dataopen_in_new

CME Group Insider Trading

Insider trading is when individuals employed by a company buy or sell its securities following legal procedures and regulations. Company executives, directors, and employees may be permitted to buy or sell shares if they follow specific rules, such as filing a Form 4 with the SEC within two business days.

Learn more at Investopediaopen_in_new


Over the last 3 months, 1 insider has sold $6.12M of common stock in CME Group on the stock market with no insider buying.

Derived from SEC.GOV filing dataopen_in_new

Debt & Income Analysis

Data is unavailable for Income Quality

Data is unavailable for Current Ratio

Value Analysis

Data is unavailable for PE Ratio

Data is unavailable for PB Ratio

Efficiency Analysis

Data is unavailable for ROE

Data is unavailable for ROCE

More Stocks